These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11325807)

  • 21. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
    Negus SS; Mello NK
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.
    Sukhtankar DD; Lee H; Rice KC; Ko MC
    Psychopharmacology (Berl); 2014 Apr; 231(7):1377-87. PubMed ID: 24217900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys.
    Kishioka S; Ko MC; Woods JH
    Eur J Pharmacol; 2000 May; 397(1):85-92. PubMed ID: 10844102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors.
    Valverde O; Ledent C; Beslot F; Parmentier M; Roques BP
    Eur J Neurosci; 2000 Feb; 12(2):533-9. PubMed ID: 10712632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term voluntary access to running wheels decreases kappa-opioid antinociception.
    D'Anci KE; Gerstein AV; Kanarek RB
    Pharmacol Biochem Behav; 2000 Jun; 66(2):343-6. PubMed ID: 10880688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of G-protein-activated inwardly rectifying K (GIRK) channels in opioid-induced analgesia.
    Ikeda K; Kobayashi T; Kumanishi T; Niki H; Yano R
    Neurosci Res; 2000 Sep; 38(1):113-6. PubMed ID: 10997585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
    Aley KO; Levine JD
    J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
    Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
    Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments.
    Ware TD; Paul D
    Eur J Pharmacol; 2000 Feb; 389(2-3):181-5. PubMed ID: 10688982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
    Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM; Angus JA; Tudor EM; Wright CE
    Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids.
    Erwin LL; Nilges MR; Denys IB; Sutphen JC; Friend AJ; Kapusta DR; Winsauer PJ
    Pharmacol Biochem Behav; 2021 Aug; 207():173218. PubMed ID: 34118232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat.
    Bolanos CA; Garmsen GM; Clair MA; McDougall SA
    Eur J Pharmacol; 1996 Dec; 317(1):1-8. PubMed ID: 8982712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of cocaine with morphine, U-50,488H and [D-Pen2, D-Pen5]enkaphalin.
    Bhargava HN; Cao YJ
    Peptides; 1998; 19(3):563-8. PubMed ID: 9533646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.